Patents Assigned to MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.K
-
Patent number: 11793911Abstract: The present invention relates to stents made of a magnesium alloy degradable under physiological conditions having an inorganic coating comprising magnesium fluoride and having an organic coating. The stents according the invention can additionally be coated with at least one antiinflammatory, antiproliferative, antiangiogenic, antirestenotic, and/or antithrombogenic active agent.Type: GrantFiled: January 2, 2018Date of Patent: October 24, 2023Assignee: MeKo Laserstrahl-Materialbearbeitungen e.K.Inventors: Clemens Meyer-Kobbe, Michael Stekker, Roman Menze
-
Publication number: 20200139017Abstract: The present invention relates to stents made of a magnesium alloy degradable under physiological conditions having an inorganic coating comprising magnesium fluoride and having an organic coating. The stents according the invention can additionally be coated with at least one antiinflammatory, antiproliferative, antiangiogenic, antirestenotic, and/or antithrombogenic active agent.Type: ApplicationFiled: January 2, 2018Publication date: May 7, 2020Applicant: MeKo Laserstrahl-Materialbearbeitungen e.K.Inventors: Clemens Meyer-Kobbe, Michael Stekker, Roman Menze
-
Patent number: 10456506Abstract: The present invention relates to pore-free polymer tubes and prefers bio-resorbable pore-free polymer tubes prepared from at least one polymer filament, wherein the at least one polymer filament has a diameter of ?50 ?m and the at least one polymer filament is melted pore-free, as well as the methods to prepare these polymer tubes, which are especially useful for the production of stents.Type: GrantFiled: December 15, 2014Date of Patent: October 29, 2019Assignee: MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.K.Inventors: Jakob Dohse, Bernd Hinrichs
-
Patent number: 9566367Abstract: The present invention is directed to a magnesium alloy containing 5.0% by wt.-25.5% by wt. dysprosium, 0.01% by wt.-5.0% by wt. neodymium and/or europium, 0.1% by wt. 3.0% by wt. zinc, 0.1% by wt.-2.0% by wt. Zirconium, and balance to 100.0% by wt. magnesium, being degradable under physiological conditions and which is particularly suitable for the production of absorbable stents and to stents made thereof.Type: GrantFiled: August 15, 2012Date of Patent: February 14, 2017Assignees: Helmholtz-Zentrum Geesthacht Zentrum fur Material-und Kustenforschung GmbH, MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.KInventors: Michael Stekker, Norbert Hort, Frank Feyerabend
-
Patent number: 9555158Abstract: The present invention is directed to a largely nickel-free iron alloy or a nickel-free stainless steel having the following composition: 14.0% by wt.-16.5% by wt. chromium 10.0% by wt.-12.0% by wt. manganese ?3.0% by wt.-4.00% by wt. molybdenum 0.55% by wt.-0.70% by wt. nitrogen 0.10% by wt.-0.20% by wt. carbon 0.00% by wt.-2.00% by wt. impurities, such as other metals, semimetals, metal salts and/or non-metals the rest up to 100% by wt. is iron, which is in particular suitable for the production of stents as well as to stents made of this alloy.Type: GrantFiled: January 15, 2013Date of Patent: January 31, 2017Assignee: MeKo Laserstrahl-Materialbearbeitungen e.KInventors: Clemens Meyer-Kobbe, Mark Rosentreter
-
Patent number: 9522219Abstract: The present invention is directed to stents made of a magnesium alloy degradable under physiological conditions and an outer polymeric coating. Herein, the stents according to the invention can be additionally coated with at least one anti-inflammatory, antiproliferative, antiangiogenic, antirestenotic and/or antithrombogenic active agent.Type: GrantFiled: August 15, 2012Date of Patent: December 20, 2016Assignees: HEMOTEQ AG, MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.KInventors: Michael Stekker, Norbert Hort, Frank Feyerabend, Erika Hoffmann, Michael Hoffmann, Roland Horres
-
Publication number: 20140364960Abstract: The present invention is directed to a largely nickel-free iron alloy or a nickel-free stainless steel having the following composition: 14.0% by wt.-16.5% by wt. chromium 10.0% by wt.-12.0% by wt. manganese ?3.0% by wt.-4.00% by wt. molybdenum 0.55% by wt.-0.70% by wt. nitrogen 0.10% by wt.-0.20% by wt. carbon 0.00% by wt.-2.00% by wt. impurities, such as other metals, semimetals, metal salts and/or non-metals the rest up to 100% by wt. is iron, which is in particular suitable for the production of stents as well as to stents made of this alloy.Type: ApplicationFiled: January 15, 2013Publication date: December 11, 2014Applicant: MeKo Laserstrahl-Materialbearbeitungen e.KInventors: Clemens Meyer-Kobbe, Mark Rosentreter
-
Publication number: 20140222133Abstract: The present invention is directed to a magnesium alloy comprising dysprosium, being degradable under physiological conditions and which is particularly suitable for the production of absorbable stents and to stents made thereof.Type: ApplicationFiled: August 15, 2012Publication date: August 7, 2014Applicants: Helmholtz-Zentrum Geesthacht Zentrum fur Material-und Kustenforschung GmbH, MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.KInventors: Michael Stekker, Norbert Hort, Frank Feyerabend
-
Publication number: 20140199365Abstract: The present invention is directed to stents made of a magnesium alloy degradable under physiological conditions and an outer polymeric coating. Herein, the stents according to the invention can be additionally coated with at least one anti-inflammatory, antiproliferative, antiangiogenic, antirestenotic and/or antithrombogenic active agent.Type: ApplicationFiled: August 15, 2012Publication date: July 17, 2014Applicants: HEMOTEQ AG, MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.KInventors: Michael Stekker, Norbert Hort, Frank Feyerabend, Erika Hoffmann, Michael Hoffmann, Roland Horres